Vafseo Tablet, Film Coated
Product Images NDC 59922-641

9 FDA label images from Akebia Therapeutics, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Vafseo (NDC 59922-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akebia Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vafseo 1)

Chemical Structure (Vafseo 1)
Chemical structure of Vadadustat, the active ingredient in VAFSEO tablets. The diagram shows the molecular arrangement including chlorine-substituted aromatic ring, hydroxyl, amide, and carboxylic acid functional groups.*
FDA Label Image

Figure 1 (Vafseo 2)

Figure 1 (Vafseo 2)
A forest plot chart titled 'Impact of Other Drugs on Pharmacokinetics of Vadadustat,' showing the geometric mean ratio (with 90% confidence intervals) for AUC and Cmax values relative to reference without interaction. The chart lists interacting drugs including Cyclosporine, Probenecid, Rabeprazole, various iron supplements and phosphate binders, and shows how these affect Vadadustat pharmacokinetics.*
FDA Label Image

Figure 2 (Vafseo 3)

Figure 2 (Vafseo 3)
A scatter plot with error bars showing the impact of Vadadustat on pharmacokinetics of other drugs. It compares changes in AUC and Cmax values relative to reference for various substrates, including HMG Co-A Reductase Inhibitors (statins), OAT1, CYP2C9, P-gp, OAT3, and BCRP substrates. The x-axis represents the geometric mean ratio with 90% confidence intervals.*
FDA Label Image

Carton Label (Vafseo 4)

Carton Label (Vafseo 4)
Packaging label for Vafseo (vadadustat) 150 mg film-coated tablets. The front panel displays the product name, generic name, strength, and tablet form, with a directive to dispense with the enclosed medication guide. The carton contains 60 tablets and is labeled for prescription use only. Manufactured for Akebia Therapeutics, Inc., with storage instructions and barcode visible on the side panels.*
FDA Label Image

60 Count Bottle Label (Vafseo 5)

60 Count Bottle Label (Vafseo 5)
Vafseo (vadadustat) 150 mg film-coated tablets label showing product name, strength, dosage form, and quantity of 60 tablets. It includes a barcode, recommended dosage instructions to swallow whole without cutting or crushing, storage temperature guidelines, and manufacturer information for Akebia Therapeutics, Inc., Cambridge, MA. Also displays a QR code and placeholder for lot and expiration dates.*
FDA Label Image

Carton Label (Vafseo 6)

Carton Label (Vafseo 6)
Packaging label for Vafseo (vadadustat) tablets, 300 mg strength. The label shows the product name, dosage form as tablets, count of 60 tablets, and is labeled for prescription use only. It is manufactured for Akebia Therapeutics, Inc., Cambridge, MA, and is a product of Spain. The label includes storage instructions and medication guide dispensing information. Several barcodes and a QR code are present along with the NDC 59922-642-60.*
FDA Label Image

60 Count Bottle Label (Vafseo 7)

60 Count Bottle Label (Vafseo 7)
Label for Vafseo (vadadustat) tablets, 300 mg strength, oral film-coated tablets, with a package count of 60 tablets. The label includes directions to swallow tablets whole and storage conditions at controlled room temperature. Manufactured for Akebia Therapeutics, Inc., Cambridge, MA, product of Spain.*
FDA Label Image

Carton Label (Vafseo 8)

Carton Label (Vafseo 8)
Packaging label for Vafseo (vadadustat) 450 mg film-coated tablets, oral use. The label displays the brand name Vafseo prominently, strength 450 mg in an orange box, and the quantity of 60 tablets. It includes the labeler information, Akebia Therapeutics, Inc., and the NDC number 59922-643-60. The label contains dosing and storage instructions, a barcode, and a medication guide notice.*
FDA Label Image

60 Count Bottle Label (Vafseo 9)

60 Count Bottle Label (Vafseo 9)
Label for Vafseo (vadadustat) tablets, film coated, 450 mg strength. The package contains 60 tablets. The label indicates the product is manufactured for Akebia Therapeutics, Inc. It includes storage instructions and a reminder to dispense with the enclosed medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.